Загрузка...
Targeted Delivery of Doxorubicin Liposomes for Her-2+ Breast Cancer Treatment
The adverse side effects and toxicity caused by the non-targeted delivery of doxorubicin has emphasized the demand of emerging a targeted delivery system. The goal of this study is to enhance the delivery of doxorubicin by formulating an aptamer-labeled liposomal nanoparticle delivery system that wi...
Сохранить в:
| Опубликовано в: : | AAPS PharmSciTech |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7995642/ https://ncbi.nlm.nih.gov/pubmed/32696338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12249-020-01743-8 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|